KRIS MOGHADAMIAN: Open Payments
NPI 1518226240 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 37 payments from 14 companies in 2025. Trend: 2023 $315 · 2024 $780 · 2025 $851
Food & beverage: $741Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $153 |
| Janssen Biotech, Inc. | 3 | $148 |
| Novartis Pharmaceuticals Corporation | 5 | $110 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $96 |
| GENZYME CORPORATION | 2 | $70 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| UCB, Inc. | 2 | $46 |
| Arcutis Biotherapeutics, Inc. | 2 | $35 |
| Incyte Corporation | 2 | $30 |
| LEO Pharma Inc. | 1 | $29 |
Products named: TREMFYA, DUPIXENT, COSENTYX, SKYRIZI, RINVOQ, Winlevi, Bimzelx, ILUMYA.
Industry payments across KY — which companies pay providers there.
